Is Tesamorelin legal in Australia?

Tesamorelin in Australia at a glance

Classification and note come from the Tesamorelin profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

• 01

  Tesamorelin reaches patients in Australia only through a prescriber, typically for a narrow labeled use or via a compounding pharmacy under a prescription.

• 02

  That route depends on a clinician's judgment and, for compounded products, on the pharmacy's own quality controls rather than a product-level marketing approval.

• 03

  Buying it online "for research use only" is outside that route, and the label does not make human use lawful.

What Tesamorelin is

An FDA-approved GHRH analogue that reduces visceral fat, now also studied for cognition in older adults at Alzheimer's risk.

Tesamorelin is a stabilized synthetic GHRH analogue approved for HIV-associated lipodystrophy, where it reduces visceral adipose tissue. It preserves the normal pulsatile pattern of GH release.

Mechanism: Activates pituitary GHRH receptors to stimulate physiological, pulsatile growth hormone release, preserving hypothalamic feedback.

Regulatory history: FDA-approved (Egrifta) for HIV-associated lipodystrophy

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Tesamorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Tesamorelin in other countries

Frequently asked questions

Related compounds in Australia